Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 698.4K | $2.0M | 4.10% | +159.1K | 2026-06-30 |
| Citadel Advisors LLC | 266.1K | -- | 1.56% | +184.2K | 2026-06-30 |
| Alyeska Investment Group, L.P. | 238.6K | -- | 1.40% | -761.4K | 2026-06-30 |
| Oppenheimer & Co Inc | 210.8K | -- | 1.24% | +14.5K | 2026-06-30 |
| Jane Street Group, LLC | 207.8K | -- | 1.22% | +184.9K | 2026-06-30 |
| BlackRock, Inc. | 167.1K | -- | 0.98% | +52.9K | 2026-06-30 |
| Renaissance Technologies LLC | 164.4K | -- | 0.96% | +95.2K | 2026-06-30 |
| Gsa Capital Partners LLP | 157.3K | -- | 0.92% | -32.4K | 2026-06-30 |
| Geode Capital Management, LLC | 155.1K | -- | 0.91% | -29.5K | 2026-06-30 |
| Summit Financial, LLC | 141.9K | -- | 0.83% | -9.9K | 2026-06-30 |
